Unnamed 1
PatientEthnicGroupCategory
text
PatientBMTCTNSubgroupRaceCategoryType
text
OtherRaceCategoryText
text
PatientSecondaryRaceBMTCTNSubgroupCategoryType
text
PatientSecondaryRaceSpecify
text
Comments
Aml T Cell Depletion - Segment A
InformedConsentFormSignedDate
date
PersonAddressPostalCode
text
PatientPaymentType
text
PersonSymptomaticPlasmaCellMyelomaClinicalTrialEligibilityCriteriaInd-2
text
PersonBirthDate
date
SystemicTherapyAdministeredInd-3
text
TreatmentBeginDate
date
TreatmentEndDate
date
StemCellMobilizationTherapyAdministeredProjectedBeginDate
date
TransplantConditioningChemotherapyAdministeredBeginDate
date
Left Ventricular Ejection Fraction
HeartLVEFTestPercentageValue
double
HeartLVEFTestDate
date
Bilirubin
LaboratoryProcedureTotalBilirubinResultValue
double
LaboratoryProcedureTotalBilirubinResultUpperLimitNormalValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Alt
LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUnspecifiedValue
double
LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Ast
LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultSpecifiedValue
double
LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultUnspecifiedUpperLimitofNormalValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Serum Creatinine
LaboratoryProcedureCreatinineClearanceOutcomeValue
double
LaboratoryProcedureCreatinineClearanceOutcomeDate
date
Dlco (corrected For Hemoglobin)
LungCarbonMonoxideDiffusingCapabilityTestAssessmentPredictiveValuePercentageValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Fev1
LungForcedExpiratoryVolume1TestSpecifiedValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Fvc
VitalLungCapacityTestSpecifiedValue
double
SpecimenLaboratoryProcedureCollectionDate
date
Unnamed2
PatientWeightMeasurement
double
PatientWeightDate
date
CD34SelectionAutograftPerformedValue
text
AssessmentLabUOM
text
Patient Exclusion Criteria
Non-SecretoryMyelomaDiseaseDiagnosisInd-2
text
PlasmaCellLeukemiaDiseaseDiagnosisInd-2
text
KarnofskyPerformanceStatusScore
text
CommonToxicityCriteriaAdverseEventPeripheralSensoryNeuropathyInd-2
text
PatientInfectionInd-2
text
HumanImmunodeficiencyVirusDiagnosisInd-3
text
CardiovascularDiseasePresentInd-2
text
PatientBortezomibBoronMannitolHypersensitivityPersonalMedicalHistoryInd-2
text
PriorInvestigationalTherapiesAdministeredInd-2
text
PatientNeoplasmPersonalMedicalHistoryIndicator
text
Exclusion Criteria (cont.)
PatientEligibilityConfirmationDate
date
PriorCancerDiagnosisIndicator
text
PatientPregnancyInd-3b
text
ContraceptionAgreementInd
text
HematopoieticStemCellTransplantationPerformedInd-2
text
PreparativeRegimenMelphalanAdministeredIndicator
text
TransplantReceivedInd-2
text
DiseaseProgressionInd-3
text
LenalidomideAgentDiscontinuedFirstMultipleMyeloma-IgGTreatmentAdministrationInd-2
text
PersonThromboembolismPersonalMedicalHistoryInd-3
text
PatientDeepVeinThrombosisPreventiveInterventionConsentInd-2
text
PatientDenyHealthInsuranceInd-2
text
Donor Inclusion Criteria
BloodTissueSpecimenOtherDiseasesandDisordersFutureResearchConsentInd-2
text
BoneMarrowSpecimenOtherDiseasesandDisordersFutureResearchConsentInd-2
text
BoneMarrowAspirateDate
date
SerumSpecimenCollectedDate
date
PlasmaSpecimenCollectedDate
date
PeripheralBloodMononuclearCellSpecimenCollectedDate
date
Risk Status
PatientRiskEligibilityDeterminationStatus
text
Hla-drb1